Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMHBQYU)

Drug Name
CAR-T cells targeting CD138 Drug Info
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Clinical trial [1]
Cross-matching ID
TTD Drug ID
DMHBQYU

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Syndecan-1 (SDC1) TTYDSVG SDC1_HUMAN CAR-T-Cell-Therapy [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Syndecan-1 (SDC1) DTT SDC1 9.603 8.243 9.155 8.159
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

ICD Disease Classification 02 Neoplasm
Disease Class ICD-11: 2C82 Prostate cancer
The Studied Tissue Bone marrow
The Studied Disease Multiple myeloma [ICD-11:2C82]
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Syndecan-1 (SDC1) DTT SDC1 1.62E-03 0.76 2.17
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 ClinicalTrials.gov (NCT03473496) CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma